The team is founded and led by Mr. Suhail Al Ansari, an experienced healthcare executive with a proven track record in developing, managing, and overseeing complex, mega healthcare initiatives in the UAE and abroad. His team of healthcare professionals with experiences in market feasibility, business and operational assessment and optimization, project development and delivery, investment and financing advisory, M&A and asset management.

With almost 20 years of experience in the healthcare industry, Mr. Suhail Al Ansari is the founder of Curis Ventures, and Deputy Vice Chairman of Gawah Holdings. He is a partner and member of the advisory board of the group’s portfolio companies, in addition to also advising numerous multinational investment houses, private equity and healthcare companies and academic medical institutions spanning from North America to Asia.

Mr. Suhail Al Ansari is also the founder and managing partner of Biolinka, which he set up in 2018 as an investment management advisory and holding company focused on growth stage innovative companies in the healthcare industry, with imminent or existing regulatory approvals, but limited market deployment, to fuel their growth and commercialization on a global scale.

Prior to Biolinka, Mr. Suhail Al Ansari formerly led the Healthcare Unit at Mubadala Investment Company as Executive Director of Healthcare for almost 12 years. As founder of the healthcare practice at Mubadala, his primary responsibilities were to oversee the development, operations and management of the healthcare assets and initiatives within the company’s portfolio.

During his tenure at Mubadala, Mr. Suhail Al Ansari established and oversaw the operations of eight healthcare businesses with globally renowned partners such as the Cleveland Clinic, Laboratory Corporation of America and Imperial College London, managing a portfolio worth over US$ 4B in assets with 6,000 employees and annual turnover exceeding US$ 750M.

Prior to Mubadala, Mr. Suhail Al Ansari worked with Dubai Holding as head of Marketing & Communications at Dubai Healthcare City. He was seconded to Dubai Holding from the Executive Office of the Crown Prince of Dubai, where he was member to the Strategy department.

Mr. Suhail Al Ansari has held numerous board positions including Chairman of the Board of Directors of The Imperial College London Diabetes Centre, Healthpoint Hospital, National Reference Laboratory, Tawam Molecular Imaging Centre, Capital Health Screening Centre, Abu Dhabi Telemedicine Centre, Viceroy Hotels and Resorts and Agility Abu Dhabi. He was also Vice Chairman of the Board Directors of Cleveland Clinic Abu Dhabi.

In addition to his healthcare specific roles, he was also the Secretary General of the Abu Dhabi – Singapore Joint Forum, an initiative created by the Executive Affairs Authority of Abu Dhabi and government of Singapore to facilitate government and private sector collaboration between Singapore and Abu Dhabi.

Mr. Suhail Al Ansari holds a Masters of Science degree in Finance from Boston College, USA, and a Bachelors of Engineering in Environmental Chemical Engineering from the University of Surrey, UK.